LT
Luminary Therapeutics, Inc.
SEC filingBiotechnology · Minneapolis, MN
Amount raised$1.4Msold at filing
Total offering$12.4M$11M still open
Investors in the raise6count reported to the SEC
FiledNov 5, 2025first sale Oct 14, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Branden MoriarityDirector
Mark ChanceDirector
Tracey LodieDirector
James HaymakerDirector, Promoter
John WellsDirector
Jeff RossDirector
Jeff LiterExecutive Officer, Director, Promoter
Executive officers, directors and promoters as listed on the Form D.